BPC-157 promotes angiogenesis (formation of new blood vessels) and accelerates healing of tendons, muscles, nerves, and ligaments
About 90% of patients in both groups were also taking riluzole (an approved ALS therapy sold as Rilutek, Tiglutik, or Exservan) during the study
It allows effective therapy with the peptide in cases of injuries and disorders of the musculoskeletal system, such as fractures, dislocations, or sprains, as well as in the regeneration of muscular system injuries, e.g., muscle tears
Unlike full-length HGH, this fragment demonstrates a more targeted activity profile, making it a subject of investigation in experimental models focused on metabolic signaling and pathway-specific regulatory mechanisms
Designed for advanced joint, tissue, gut, and neurological support, this version includes an absorption enhancer (SNAC) to help the peptide be efficiently delivered and utilized
The information below reflects USP standards, manufacturer prescribing information, published trial protocols, and self-reported community sources
